C1-esterase inhibitor treatment: preclinical safety aspects on the potential prothrombotic risk. [electronic resource]
Producer: 20150728Description: 960-71 p. digitalISSN:- 2567-689X
- Animals
- Arterial Occlusive Diseases -- chemically induced
- Blood Coagulation Tests
- Complement C1 Inhibitor Protein -- administration & dosage
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Drug Evaluation, Preclinical
- Factor XIIa -- analysis
- Factor XIa -- analysis
- Femoral Artery
- Fibrinolysis -- drug effects
- Humans
- Infusions, Intravenous
- Kallikrein-Kinin System -- drug effects
- Platelet Aggregation -- drug effects
- Rabbits
- Thrombelastography
- Thrombin -- biosynthesis
- Venous Thrombosis -- chemically induced
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.